Auxology and growth assessment

Irish Medical Journal

Volumn 98, Issue 6, 2005, Pages

  Hoey, Hilary ^b   Roche, E F ^a   Meehan, J ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

^b OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CLONIDINE; GLUCAGON; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; LEVODOPA; PROPRANOLOL; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ANTHROPOMETRIC PARAMETERS; ARTICLE; BIRTH WEIGHT; BODY HEIGHT; CHILD DEVELOPMENT; CHILD GROWTH; DOWN SYNDROME; ENDOCRINE FUNCTION; FAMILY HISTORY; GESTATIONAL AGE; GROWTH DISORDER; GROWTH HORMONE RELEASE; HUMAN; IRELAND; MEDICAL PRACTICE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PUBERTY; SHORT STATURE; UNITED KINGDOM;

BODY HEIGHT; CHILD; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS;

EID: 23744489679     PISSN: 03323102     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Hoey H. Early recognition of short stature. J Postgrad Med 1987; 424-432
2. Hoey H. Psycho-social aspects of short stature. J Pediatr Endocrinol 1993; 6: 291-294
3. Hindmarsh P. Monitoring children's growth. BMJ 1996; 312: 122a
4. Roche E. Childhood Obesity. IMJ 2003; 96: 4, 100-102
5. Deckelbaum RJ, Williams CL. Childhood Obesity: The Health Issue. Obes Res 2001; 9: 239S-243S
6. Reilly JJ, Dorosty A. Epidemic of Obesity in UK Children. The Lancet 1999; 354(27): 1874-1875
7. Dietz WH. Health consequences of obesity in youth: childhood predictors of adult disease. Paediatrics 1998; 108: 518-25
8. Vanhala M, Vanhala P, Kumpusalo E, et al. Relation between obesity from childhood to adulthood and the metabolic syndrome: population based study. BMJ 1998; 317-319
9. Hall DMB, Elliman D. Health for all children, Oxford University Press; 4th Edition, 2003
10. Haschke F, van't Hof M, Darvay S and the Euro-Growth Study Group, Ireland: Freeman V, Hoey H, Gibney M. Euro-Growth References for Length, Weight and Body Circumferences. J Pediatr Gastroerterol Nutr 2000; 31; Sup 1, 14-38
11. Eveleth P, Tanner J. World wide variation in human growth, London. Cambridge University Press 1976; 213-21
12. Hoey H. Short Stature, Pathways in Paediatrics, Ed. Loftus BG, London; Edward Arnold, London, 1995; 245-254
13. Hoey H. Abnormal Puberty, Pathways in Paediatrics, Ed. Loftus BG, London; Edward Arnold, 1995; 127-134
14. Hoey H. The design and use of growth standards. Growth Matters 1991; 7: 2-4
15. Hoey H. Auxology: The Irish Contribution: Essays on Auxology. Ed. Hauspe R, Lingren G, Falkner F. U K; Castlemead Publications, 1995; 201-210
16. Hoey H, Tanner J, Cox L. Clinical Growth standards for Irish children. Acta Paed Scand Supplement 1987; 388: 1-31
17. Freeman JV, Cole TJ, Chinn S, et al. Cross-sectional stature and weight reference curves for the UK 1990. Arch Dis Child 1995; 73: 17-24
18. Hoey H, Cox L, Tanner J. The age of menarche in Irish girls. IMJ 1986; 79: 283-285
19. Reilly JJ. Assessment of childhood obesity: national reference data or international approach? Obes Res 2000; 10(8):838-840
20. Hulse JA, Shilg S. Relation between height and weight centiles may be more useful. BMJ 1996; 312: 122
21. Hoey H, Cox LA. Irish standards for triceps and subscapsular skin fold thickness. IMJ 1980, 11, 121-321
22. Noey H, Cox LA. Head circumference standards for Irish children. Acta Paed Scand 1990; 79: 283-88
23. Parvin M, Roche E, Hoey H, et al. Treatment Outcome in Turner Syndrome IMJ 2004; 97: 1, 12-15
24. Styles ME, Cole TJ, Dennis J, Preece MA. New cross sectional stature, weight, and head circumference references for Down's syndrome in the UK and Republic of Ireland. Arch Dis Child 2001; 87 (2): 104-108
25. Mehta A, Hindmarsh P. The use of Somatropin (recombinant growth hormone) in children of short stature. Paediatr Drugs 2002; 4 (1): 37-47
26. Guidance on the use of human growth hormone (Somatropin) in children with growth failure. National Institute of Clinical Excellence (NICE). London, 2002
27. Harper J, Philip M, Murphy J, Hoey H, Growth in Irish children and adolescents with Down Syndrome, from 3 months to 18 years. Ir J Med Sci 2000; 1: Sup 2, 64-65